Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicole Frahm

Showing results (21-30 of 115) with videos related to

Pageof 12
Sort By:
Clinical Microbiology Reviews|March 21, 2022
Tuberculosis Treatment Monitoring and Outcome Measures: New Interest and New StrategiesJan Heyckendorf, Sophia B Georghiou, Nicole Frahm, et al.
Vaccine|December 3, 2014
Use of placebos in Phase 1 preventive HIV vaccine clinical trialsYunda Huang, Shelly T Karuna, Holly Janes, et al.
Journal of Virology|May 18, 2007
MyD88-dependent immune activation mediated by human immunodeficiency virus type 1-encoded Toll-like receptor ligandsAngela Meier, Galit Alter, Nicole Frahm, et al.
Plos One|September 6, 2007
Recognition of HIV-1 peptides by host CTL is related to HIV-1 similarity to human proteinsMorgane Rolland, David C Nickle, Wenjie Deng, et al.
Journal of Virology|January 11, 2008
Increased cytotoxic T-lymphocyte epitope variant cross-recognition and functional avidity are associated with hepatitis C virus clearanceDaniel Yerly, David Heckerman, Todd M Allen, et al.
Journal of Immunological Methods|May 28, 2013
Optimization and qualification of a memory B-cell ELISpot for the detection of vaccine-induced memory responses in HIV vaccine trialsPaula N Walsh, David P Friedrich, Julie A Williams, et al.
The Journal of Clinical Investigation|March 20, 2002
Expansion of pre-existing, lymph node-localized CD8+ T cells during supervised treatment interruptions in chronic HIV-1 infectionMarcus Altfeld, Jan van Lunzen, Nicole Frahm, et al.
Journal of Immunological Methods|April 2, 2014
The External Quality Assurance Oversight Laboratory (EQAPOL) proficiency program for IFN-gamma enzyme-linked immunospot (IFN-γ ELISpot) assayAna M Sanchez, Wes Rountree, Mark Berrong, et al.
The Journal of Infectious Diseases|February 1, 2011
Host genetic determinants of T cell responses to the MRKAd5 HIV-1 gag/pol/nef vaccine in the step trialJacques Fellay, Nicole Frahm, Kevin V Shianna, et al.
Journal of Immunological Methods|May 26, 2012
Optimization and qualification of a multiplex bead array to assess cytokine and chemokine production by vaccine-specific cellsOlivier D Defawe, Youyi Fong, Evgenia Vasilyeva, et al.
Pageof 12

Showing results (21-30 of 115) with videos related to

Sort By:
Pageof 12
Clinical Microbiology Reviews|March 21, 2022
Tuberculosis Treatment Monitoring and Outcome Measures: New Interest and New StrategiesJan Heyckendorf, Sophia B Georghiou, Nicole Frahm, et al.
Vaccine|December 3, 2014
Use of placebos in Phase 1 preventive HIV vaccine clinical trialsYunda Huang, Shelly T Karuna, Holly Janes, et al.
Journal of Virology|May 18, 2007
MyD88-dependent immune activation mediated by human immunodeficiency virus type 1-encoded Toll-like receptor ligandsAngela Meier, Galit Alter, Nicole Frahm, et al.
Plos One|September 6, 2007
Recognition of HIV-1 peptides by host CTL is related to HIV-1 similarity to human proteinsMorgane Rolland, David C Nickle, Wenjie Deng, et al.
Journal of Virology|January 11, 2008
Increased cytotoxic T-lymphocyte epitope variant cross-recognition and functional avidity are associated with hepatitis C virus clearanceDaniel Yerly, David Heckerman, Todd M Allen, et al.
Journal of Immunological Methods|May 28, 2013
Optimization and qualification of a memory B-cell ELISpot for the detection of vaccine-induced memory responses in HIV vaccine trialsPaula N Walsh, David P Friedrich, Julie A Williams, et al.
The Journal of Clinical Investigation|March 20, 2002
Expansion of pre-existing, lymph node-localized CD8+ T cells during supervised treatment interruptions in chronic HIV-1 infectionMarcus Altfeld, Jan van Lunzen, Nicole Frahm, et al.
Journal of Immunological Methods|April 2, 2014
The External Quality Assurance Oversight Laboratory (EQAPOL) proficiency program for IFN-gamma enzyme-linked immunospot (IFN-γ ELISpot) assayAna M Sanchez, Wes Rountree, Mark Berrong, et al.
The Journal of Infectious Diseases|February 1, 2011
Host genetic determinants of T cell responses to the MRKAd5 HIV-1 gag/pol/nef vaccine in the step trialJacques Fellay, Nicole Frahm, Kevin V Shianna, et al.
Journal of Immunological Methods|May 26, 2012
Optimization and qualification of a multiplex bead array to assess cytokine and chemokine production by vaccine-specific cellsOlivier D Defawe, Youyi Fong, Evgenia Vasilyeva, et al.
Pageof 12